The case for & against
Bull & Bear analysis
Celsius Holdings, Inc. (NASDAQ: CELH) is a rapidly growing player in the functional beverage sector, with a focus on energy drinks that emphasize health and wellness. The company operates flagship brands including Celsius, Alani New, and Rockstar Energy, positioning itself strategically for growth in the beverage market by capitalizing on the increasing consumer trend for healthier energy alternatives. With a significant partnership with PepsiCo, Celsius aims to enhance its market reach and operational efficiency, thereby strengthening its position in a competitive industry.
Bull says
- ↑Q1 2026 revenue of $783 M (+35% YoY) driven by brand integration.
- ↑Alani New acquisition delivered 60% pro forma growth, unlocking $50 M PepsiCo synergies.
- ↑Gross margin at 48.3%, expecting low-50% range by Q3 2026.
- ↑20.9% energy drink market share amid health-focused consumer trends.
- ↑Cash on hand of $615 M ensures funding for expansion and innovation.
- ↑Strong growth profile and high liquidity underpin potential stock upside.
Bear says
- ↓Rising aluminum and commodity costs could push margin recovery past mid-2026.
- ↓Weak earnings yield and negative estimate revisions suggest overvaluation risk.
- ↓High short interest reflects investor skepticism on near-term performance.
- ↓Intense competition from Monster and Red Bull demands constant product innovation.
- ↓Reliance on limited-time offers risks stagnation if consumer demand falters.
- ↓Deteriorating momentum indicators point to potential downside volatility.
Investment themes with CELH
Stocks with high short interest ratios
Earnings Call · Q1 2026 · Mgmt. Guidance
Transcript signals
Bull points
- we delivered record first quarter revenue of $783 million, reflecting continued strength across the portfolio and solid execution against the operating priorities we laid out coming into 2026.
- As we discussed last quarter, we have been focused on tightening the alignment between shipments and underlying consumer takeaway, and we saw progress on that front in Q1.
- the underlying business is healthy and scanner growth remains strong.
Bear points
- if elevated costs do remain across the year, we may see some impact on the timing and sequencing of our ramp back to the low 50s.
- As Jared mentioned on the prior question, if those stay at sustained higher levels, it could provide further impact.